MedTrace Logo

A Novel Healthcare Information Technology Tool to Improve Care in Patients With Atrial Fibrillation

NCT02623517 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2022-08-05

No results posted yet for this study

Summary

Patients with implantable heart devices including pacemakers, defibrillators, and cardiac monitors may not seek regular medical care related to their implanted devices. These devices are capable of detecting abnormal heart rhythms or other device abnormalities that may benefit from clinical action or oversight. A novel healthcare information technology has been developed and is being implemented clinically for screening of patients with cardiac rhythm devices who seek care in the emergency room setting. This study seeks to examine differences in detection of cardiac rhythm disturbances including atrial fibrillation (AF) with utilization of this new screening technology, and how often treatment plans change in patients who have a heart rhythm abnormality detected.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jonathan Hsu, MD · UC San Diego School of Medicine; Sulpizio Cardiovascular Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2021-07-01
Completion
2021-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02623517 on ClinicalTrials.gov